KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Aug 12, 2021 $123.11 $124.46 $120.64 $122.93 183 323
Aug 11, 2021 $124.30 $125.41 $122.42 $123.26 115 642
Aug 10, 2021 $125.56 $126.55 $123.20 $124.42 188 921
Aug 09, 2021 $124.76 $126.98 $121.97 $125.43 137 350
Aug 06, 2021 $128.16 $128.25 $122.03 $124.57 232 833
Aug 05, 2021 $127.36 $128.49 $124.64 $127.38 250 964
Aug 04, 2021 $122.25 $127.09 $122.25 $126.50 261 450
Aug 03, 2021 $124.66 $124.66 $121.76 $123.01 428 529
Aug 02, 2021 $125.00 $127.14 $124.56 $124.72 303 090
Jul 30, 2021 $126.47 $128.95 $124.70 $125.06 288 816
Jul 29, 2021 $125.00 $128.75 $124.37 $126.99 248 043
Jul 28, 2021 $117.77 $125.58 $116.77 $124.75 308 423
Jul 27, 2021 $119.85 $121.57 $115.13 $116.94 264 525
Jul 26, 2021 $122.25 $123.74 $119.85 $120.19 294 977
Jul 23, 2021 $122.70 $123.81 $120.76 $122.81 121 941
Jul 22, 2021 $121.22 $122.80 $120.33 $122.21 171 640
Jul 21, 2021 $121.14 $121.81 $118.70 $121.19 241 575
Jul 20, 2021 $118.60 $121.89 $117.90 $121.49 340 102
Jul 19, 2021 $116.63 $119.74 $115.09 $118.32 294 387
Jul 16, 2021 $115.65 $118.39 $114.56 $117.26 192 721
Jul 15, 2021 $115.29 $117.11 $113.49 $115.36 242 955
Jul 14, 2021 $116.23 $116.66 $114.86 $115.25 293 533
Jul 13, 2021 $117.28 $118.55 $115.18 $116.40 323 368
Jul 12, 2021 $120.04 $122.46 $117.19 $117.28 349 498
Jul 09, 2021 $119.58 $121.69 $118.02 $120.24 177 897
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT